DR. KAORU NOZUExecutive Representative, pharmaceutical


47 years experience in the Japanese pharma market

Former Management Board Member of Aventis Japan (now Sanofi)
Former Advisor for Sanofi Pasteur

Has been involved in 11 major M&A/JV transactions with major pharmaceutical companies in Japan, USA and EU
Has been involved in acquisition of 11 major branded products
Has been the lead negotiator for in and out-licensing of several major branded products, e.g. Camptothecin (Irinotecan), G-CSF and Docetexol
2007 – 2013 Advisor to Actavis Group
Dr. Nozu lead the establishment of the JV with Aska Pharma, a Takeda Group company, in 2009 for Actavis Group

PhD. in Pharma Science from Kyoto University
Scientist at National Institute of Radiological Medicines, Chiba
Visiting scientist at NIH, Bethesda, USA

MR. TAKAO MIYAMOTOExecutive Vice Representative, pharmaceutical


46 years experience in the Japanese Pharmaceutical market

Former management executive of Astellas and former Operating Officer at Kyowa Hakko Kirin, two of the largest pharmaceutical companies in Japan

Has successfully finalized many M&A and licensing deals throughout his career
Broad expertise in the international pharmaceutical business
Was instrumental in launching blockbuster products, such as Flomax (then world ‘s #1 urology product), in multiple countries

Kyoto University Graduate in Pharma Science

Bolli Thoroddsen
MR. BOLLI THORODDSENBusiness development, pharmaceutical, cosmetics, energy, financing


9 years of experience in the in the Japanese Pharmaceutical and Energy market

Since 2013 Chairman of the Icelandic Chamber of Commerce in Japan
2009 – 2010 Advisor to Actavis Group and its subsidiary MEDIS Pharma (oncology business)
2009 – 2010 Advisor to Iceland Embassy in Japan
2007 – 2009 Project Manager at Actavis Group. Mr. Thoroddsen was among others instrumental in Actavis’ entry into the Japanese market by establishing a JV with Aska, a Takeda Group company
2006 – 2010 Elected 2nd Deputy Council Member for Reykjavik’s City Council

Ph.D. candidate at Waseda University (Currently on leave of absence)
M.Sc. in Finance from Waseda University in Japan (Japanese Ministry of Education Scholarship Student, Monbusho Scholarship)
B.Sc. in Industrial Engineering, University of Iceland

MR. BJÖRN PÉTURSSONBusiness development


20 years of experience in business development, banking, trade and sales in Europe and Asia

2008 – 2014 Landsbankinn hf. Senior Director at Corporate restructuring, responsible for the workout of corporate loans
2004 – 2007 Kaupas Supermarkets, Head of purchasing, procurement and logistics
LS Retail and Hugvit, Head of international sales and marketing
Marel Food Systems, Area Sales Manager, Emerging markets, Japan

M.Sc. Tokyo Kaiyo University and Tokyo Institute of Technology. Engineering and Japanese language studies (Japanese Ministry of Education Scholarship Student, Monbusho Scholarship)
C.Sc.  University of Iceland in Industrial/Mechanical Engineering



2010 – 2015 Landsbankinn hf. – Corporate Restructuring
2006 – 2008, 2009 – 2010 Landsbankinn hf. – Corporate Banking
2003 – 2005 Eskill ehf. (Software & Consulting) – Account Manager

Cass Business School London – MSc in Banking and International Finance
University of Reykjavik – Securities Broker License
University of Iceland – BSc in Business (exchange program at Copenhagen Business School)



Over 10 years experience in cross-cultural business development, organizational operations and management

Since 2015 Takanawa
2009 – 2013 Trade representative of the Embassy of Iceland. Explored business opportunities and built cooperative relationships with leading Japanese companies in wide-range of industries
2001 – 2008 Personal assistant to the Ambassador and coordinated and promoted political, trade and cultural relations while contributing to the newly established Embassy’s operation

MBA. Hult International Business School in London campus, UK
B.A. University of Iceland. Icelandic and Icelandic literature, Icelandic government scholarship student

NATSUMI HASEBECosmetics & consumer goods


Since 2016 Takanawa
2015 – 2016 En world Japan, Secretary to Executive Vice President
2014 – 2015 China Airlines, Cabin Crew
2010 – 2013 Emirates Airlines, Cabin Crew
2009 – 2010 Walt Disney World Resort, Retail

B.A Sophia University, Faculty of Liberal Arts

DR. KATSUSHIGE GOMIScientific Director, pharmaceutical


41 years experience in the Japanese pharma market

Since 2017 Takanawa Pharma
Former Senior Officer of Nichi-Iko
2013 Director, Global Study Clinical Research Dept., CMIC
2005 – 2013 Former Deputy General Manager at Yakult
Involved in the Clinical Development and Medical Affairs of irinotecan and oxaliplatin
1975 – 2005 Researcher, Managing Researcher, Deputy General Manager, General Manager at Kyowa Hakko
Involved in the clinical development of istradefylline
Involved in the preclinical study of 5-fluorouracil, mitomycin C, adriamycin, farmorubicin, vinorelbine, medroxyprogesterone and G-CSF

Tokyo University Graduate in Pharma Science
Ph.D. in Pharma Science from Tokyo University
Visiting scientist at Japanese Foundation for Cancer Research
Visiting scientist at NCI, Bethesda, USA

MR. JOHAN WESTBLADPharmaceutical


16 years experience in the Japanese pharma market

Since 2014 Advisor, Business Development, Takanawa Pharma
Since 2014 Founder & Managing Director, Aurora Partners K.K.
2004 – 2014: Manager & Associate Director, Business Develop, Quintiles Transnational Japan
Primarily assisted foreign companies with regulatory strategy and clinical development to get accelerated access to Japanese market
2000 – 2004: Manager, Life Sciences, Invest Sweden, Embassy of Sweden, Tokyo

MBA from McGill University, Desautels Faculty of Management, Finance Specialization
M.Sc. in International Business, Gothenburg University, School of Business, Economics and Law

MR. JEAN-PIERRE FEREPharmaceutical


37 years experience in the Japanese pharma market

Since 2015 Takanawa Pharma
Since 1999 Advisor to major pharma companies
From 1995 Representative Director of the JV between Synthélabo group (Now part of Sanofi) and Fujisawa (Now Astellas) in Taiwan
From 1993 General Manager of Synthélabo Pharmaceuticals KK (Now part of Sanofi)
From 1992 Representative in Japan of Synthélabo Group, after the merger of Delagrange Group and Synthélabo Group
From 1982 Representative Director of the JV between Delagrange group and Fujisawa in Japan
From 1973 Representative of Delagrange Group in Japan

B.Sc. in Physics&Chemistry, Paris Univ. (Sorbonne)

MARGRÉT S. BJÖRNSDÓTTIRCorporate social responsibility and administration


40 years of experience in administration, Icelandic politics and higher education

2004 – Present Adjunct Lecturer on Public Leadership and Change Management, Department of Political Science, MPA. University of Iceland. Editorial board, Journal on Politics and Public Administration
2002 – Present Honorary Consul of Nicaragua in Iceland
1976 – Present Member and chairman of numerous boards and committees for The Social Democratic Party.
2009 – 2013 Chairman of the National Executive Board of Social Democratic party of Iceland
2002 – 2010 Executive director of The Institute for Public Administration and Politics, U of Iceland
1998 – 2002 Director of Development and Public Relations, University of Iceland
1993 – 1995 Political Assistant and consultant to the Minister of Industry and Commerce
1983 – 1998 Executive director of The Institute for Continuing Education, University of Iceland

Master in Public Administration, Harvard, J. F. Kennedy School of Government, USA
MA-degree, Diplom-Soziologe, Johann W. Goethe Universität, Frankfurt am Main, Germany